VolitionRx (VNRX) grants 187,000 RSUs to General Counsel Plummer

Rhea-AI Filing Summary

VolitionRx Ltd reported that General Counsel of Volition Diagnostics, Nicholas Plummer, acquired an award linked to 187,000 restricted stock units (RSUs) on common stock under the company’s 2024 Stock Incentive Plan, in lieu of cash compensation otherwise payable to him.

The RSUs are scheduled to be earned in twelve approximately equal monthly installments starting on March 1, 2026, then subject to additional time-based vesting in a single installment on February 26, 2027, contingent on his continued service. Upon vesting and settlement, he will receive one share of common stock for each earned and vested RSU. Following this award, his directly held common stock position is reported as 420,137 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Plummer Nicholas

(Last) (First) (Middle)

1489 WEST WARM SPRINGS ROAD

SUITE 110

(Street)

HENDERSON NV 89014

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [ VNRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GC - Volition Diagnostics

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		A		187,000(1)	A	$0	420,137	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On February 26, 2026, the reporting person was awarded 187,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.

Remarks:

	/s/ Nicholas Plummer	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Nicholas Plummer receive in the VolitionRx (VNRX) Form 4 filing?

Nicholas Plummer received an award tied to 187,000 restricted stock units (RSUs) on VolitionRx common stock. The award was granted under the 2024 Stock Incentive Plan as compensation in lieu of cash otherwise owed to him.

How and when will Nicholas Plummer’s 187,000 VolitionRx RSUs be earned and vested?

The 187,000 RSUs will be earned in twelve approximately equal monthly installments starting March 1, 2026. Once earned, they vest in a single time-based installment on February 26, 2027, generally requiring continued service through each applicable date.

Does Nicholas Plummer receive cash or stock for this VolitionRx compensation award?

He receives restricted stock units instead of cash compensation. The RSUs are issued in lieu of cash that would otherwise be owed and, upon vesting and settlement, convert into an equal number of VolitionRx common shares.

What happens to the 187,000 VolitionRx RSUs when they vest for Nicholas Plummer?

Upon vesting and settlement, Nicholas Plummer will receive one share of VolitionRx common stock for each RSU that has been earned and vested. This means up to 187,000 common shares could be delivered if all RSUs vest.

What is Nicholas Plummer’s reported VolitionRx common stock ownership after this Form 4 transaction?

After the reported transaction, Nicholas Plummer’s direct ownership is listed as 420,137 shares of VolitionRx common stock. This figure reflects his holdings following the RSU-related acquisition reported in the filing.

Under which plan were Nicholas Plummer’s VolitionRx RSUs granted and why?

The 187,000 RSUs were granted under VolitionRx’s 2024 Stock Incentive Plan. They were awarded specifically in lieu of cash compensation that otherwise would have been owed to Nicholas Plummer for his services.